Identification of conformational and cold-sensitive mutations in the MuLV Envelope protein

Virology

Volumn 312, Issue 2, 2003, Pages 337-349

  O’reilly, Lucille ^a   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ENVELOPE PROTEIN; MURINE LEUKEMIA VIRUS SURFACE PROTEIN; MUTANT PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIS ISOMER; COLD SENSITIVITY; CONTROLLED STUDY; IMMUNOPRECIPITATION; MOLECULAR RECOGNITION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETROVIRUS;

MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0041561134     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00244-7     Document Type: Article

References (53)

1. Albritton L.M., Tweng L., Scadden D., Cunningham J.M. A putative murine retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell. 57:1989;659-666.
2. Bae Y., Kingsman S.M., Kingsman A.J. Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J. Virol. 71:1997;2092-2099.
3. Barnett A.L., Davey R.A., Cunningham J.M. Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc. Natl. Acad. Sci. USA. 98:(7):2001;4113-4118.
4. Barnett A.L., Wensel D.L., Li W., Fass D., Cunningham J.M. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J. Virol. 77:2003;2717-2729.
5. Battini J.-L., Danos O., Heard J.M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69:(2):1995;713-719.
6. Battini J.-L., Rodrigues P., Muller R., Danos O., Heard J.M. Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J. Virol. 70:1996;4387-4393.
7. Berkowitz R.D., Goff S.P. Point mutations in Moloney murine leukemia virus envelope protein effects on infectivity, virion association, and superinfection resistance . Virology. 196:(2):1993;748-757.
8. Carr C.M., Chaudhry C., Kim P.S. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc. Natl. Acad. Sci. USA. 94:1997;14306-14313.
9. Carr C.M., Kim P.S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
10. Carr C.M., Kim P.S. Flu virus invasion halfway there . Science. 266:1994;234-236.
11. Evans L.H., Morrison R.P., Malik F.G., Portis J., Britt W.J. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:1990;6176-6183.
12. Fass D., Davey R.A., Hamson C.A., Kim P.S., Cunningham J.M., Berger J.M. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 A resolution. Science. 277:1997;1662-1666.
13. Fass D., Harrison S.C., Kim P.S. Retrovirus envelope domain at 1.7 A resolution. Nat. Struct. Biol. 3:(5):1996;465-468.
14. Felkner R.H., Roth M.J. Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J. Virol. 66:(7):1992;4258-4264.
15. Galisteo M.L., Gordon C.L., King J. Stability of wild-type and temperature-sensitive protein subunits of the phage P22 capsid. J. Biol. Chem. 270:(28):1995;16595-16601.
16. Goff S.P., Traktman P., Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants; use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:1981;239-248.
17. Gordon C.L., King J. Temperature-sensitive mutations in the phage P22 coat protein which interfere with polypeptide chain folding. J. Biol. Chem. 268:(13):1993;9368-9368.
18. Gray K.D., Roth M. Mutational analysis of the envelope gene of Moloney murine leukemia virus. J. Virol. 67:(6):1993;3489-3496.
19. Hernandez L.D., Hoffman L.R., Wolfsberg T.G., White J.M. Virus-cell and cell-cell fusion. Ann. Rev. Dev. Biol. 12:1996;627-661.
20. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:1967;365-369.
21. Johnston E.R., Albritton L.M., Radke K. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein. J. Virol. 76:2002;10861-10872.
22. Lavillette D., Boson B., Russell S.J., Cosset F.-L. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J. Virol. 75:(8):2001;3685-3695.
23. Lavillette D., Maurice M., Roche C., Russell S., Sitbon M., Cosset F.-L. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J. Virol. 72:1998;9955-9965.
24. Lavillette D., Ruggieri A., Boson B., Maurice M., Cossett F.L. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein. J. Virol. 76:2002;9673-9685.
25. Lavillette D., Ruggieri A., Russell S.J., Cossett F.-L. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J. Virol. 74:(1):2000;295-304.
26. Li X., McDermott B., Yuan B., Goff S.P. Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus. J. Virol. 70:1996;1266-1270.
27. Lu C.-W., Roth M.J. Functional characterization of the N-termini of murine leukemia virus envelope protein. J. Virol. 75:2001;4357-4366.
28. Lu, C.-W., Roth, M.J., (2003). Functional interaction between the N- and C-terminal domains of murine leukemia virus surface envelope protein. Virology 310, 131-141.
29. MacKrell A.J., Soong N.W., Curtis C.M., Anderson W.F. Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J. Virol. 70:1996;1768-1774.
30. McCutchan J.H., Pagano J.S. Enhancement of infectivity of SV40 deoxyribonucleic acid with DEAE dextran. J. Natl. Cancer Inst. 41:1968;351-357.
31. O'Reilly L., Roth M.J. Second-site changes affect viability of amphotropic/ecotropic chimeric-enveloped MuLVs. J. Virol. 74:2000;899-913.
32. Ott D., Friedrich R., Rein A. Sequence analysis of amphotropic and 10A1 Murine leukemia viruses; close relationship to mink cell focus-inducing viruses. J. Virol. 64:1990;757-766.
33. Peredo C., O'Reilly L., Gray K., Roth M.J. Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J. Virol. 70:(5):1996;3142-3152.
34. Pinter A., Honnen W.J., Tung J.-S., O'Donnell P.V., Hammerling U. Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology. 116:1982;499-516.
35. Pinter A., Kopelman R., Li Z., Kayman S.C., Sanders D.A. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. J. Virol. 71:(10):1997;8073-8077.
36. Ragheb J.A., Yu H., Hoffman T., Anderson W.F. The amphotropic and ecotropic murine leukemia virus envelope TM subunits are equivalent mediators of direct membrane fusion implications for the role of ecotropic envelope and receptor in syncytium formation and viral entry . J. Virol. 69:1995;7205-7215.
37. Rein A., Mirro J., Haynes J.G., Ernst S.M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus env protein . J. Virol. 68:(3):1994;1773-1781.
38. Rothenberg S.M., Olsen M.N., Laurent L.C., Crowley R.A., Brown P.O. Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein. J. Virol. 75:(23):2001;11851-11862.
39. Sanders D.A. Sulfhydryl involvement in fusion mechanisms. Subcell. Biochem. 34:2000;483-514.
40. Shinnick T.M., Lerner R.A., Sutcliffe J.G. Nucleotide sequence of Moloney murine leukaemia virus. Nature. 293:1981;543-548.
41. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:(4):1995;629-633.
42. Tailor C.S., Kabat D. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J. Virol. 71:(12):1997;9383-9391.
43. Tailor X.S., Nouri A., Kabat D. A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors. J. Virol. 74:(1):2000;237-244.
44. Thomas A., Gray K.D., Roth M.J. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein. Virology. 227:1997;305-313.
45. Thomas A., Roth M.J. Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus. Virology. 211:1995;285-289.
46. Vogelstein B., Gillespie D. Preparative and analytical purification of DNA from agarose. Proc. Natl. Acad. Sci. USA. 76:1979;615-619.
47. Wu B.W., Cannon P.M., Gordon E.M., Hall F.L., Anderson W.F. Characterization of the proline-rich region of murine leukemia virus envelope protein. J. Virol. 72:(7):1998;5383-5391.
48. Xiang S.-H., Kwong P.D., Gupta R., Rizzuto C.D., Casper D.J., Wyatt R., Wang L., Hendrikson W.A., Doyle M.L., Sodroski J. Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type I gp120 envelope glycoprotein. J. Virol. 76:2002;9888-9899.
49. Yang C., Compans R.W. Analysis of the murine leukemia virus R peptide delineation of the molecular determinants which are important for its fusion inhibition activity . J. Virol. 71:(11):1997;8490-8496.
50. Zavorotinskaya T., Albritton L.M. Failure to cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interactions. J. Virol. 73:(7):1999;5621-5629.
51. Zavorotinskaya T., Albritton L.M. Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein. J. Virol. 73:(6):1999;5034-5042.
52. Zhao Y., Zhu L., Benedict C.A., Chen D., Anderson W.F., Cannon P.M. Functional domains in the retroviral transmembrane protein. J. Virol. 72:(7):1998;5392-5398.
53. Zhu N.-L., Cannon P.M., Chen D., Anderson W.F. Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrante protein p15E. J. Virol. 72:1998;1632-1639.